Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial
Titel:
Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial
Auteur:
Saad, Fred Thiery-Vuillemin, Antoine Wiechno, Pawel Alekseev, Boris Sala, Nuria Jones, Robert Kocak, Ivo Chiuri, Vincenzo Emanuele Jassem, Jacek Fléchon, Aude Redfern, Charles Kang, Jinyu Burgents, Joseph Gresty, Christopher Degboe, Arnold Clarke, Noel W